Assured Pharmacy Inc (APHY) financial statements (2020 and earlier)

Company profile

Business Address 5600 TENNYSON PARKWAY
PLANO, TX 75024
State of Incorp. NV
Fiscal Year End December 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments321
Cash and cash equivalents321
Receivables324677
Disposal group, including discontinued operation4 
Prepaid expense and other current assets147
Other undisclosed current assets499410
Total current assets:8301,256
Noncurrent Assets
Property, plant and equipment7861
Intangible assets, net (including goodwill)698
Goodwill 698
Assets of disposal group, including discontinued operation141 
Other undisclosed noncurrent assets 207
Total noncurrent assets:219966
TOTAL ASSETS:1,0492,221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,6434,850
Accrued liabilities39 
Other undisclosed accounts payable and accrued liabilities1,6034,850
Debt4263,000
Other undisclosed current liabilities508(282)
Total current liabilities:2,5777,568
Noncurrent Liabilities
Liabilities, other than long-term debt789447
Due to related parties477447
Derivative instruments and hedges, liabilities312 
Other undisclosed noncurrent liabilities5,633694
Total noncurrent liabilities:6,4221,141
Total liabilities:8,9998,709
Stockholders' equity
Stockholders' equity attributable to parent, including:(10,466)(6,487)
Common stock104
Additional paid in capital38,14236,572
Accumulated deficit(48,618)(43,064)
Warrants and rights outstanding1,060275
Other undisclosed stockholders' equity attributable to parent(1,060)(275)
Other undisclosed stockholders' equity2,515 
Total stockholders' equity:(7,950)(6,487)
TOTAL LIABILITIES AND EQUITY:1,0492,221

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues5,19314,146
Revenue, net9,734 
Cost of revenue(4,072)(11,078)
Cost of goods and services sold(1,741) 
Gross profit:1,1203,067
Operating expenses(4,020)(5,864)
Other operating income (expense), net
(Other Expenses)
(475)1,208
Other undisclosed operating loss (1,208)
Operating loss:(3,375)(2,797)
Interest and debt expense287(1,566)
Other undisclosed income from continuing operations before equity method investments, income taxes336 
Loss from continuing operations before equity method investments, income taxes:(2,752)(4,363)
Other undisclosed loss from continuing operations before income taxes(2,193) 
Loss from continuing operations before income taxes:(4,945)(4,363)
Income tax expense (benefit)(328)1,362
Other undisclosed loss from continuing operations (1,005)
Loss from continuing operations:(5,273)(4,006)
Loss from discontinued operations(609) 
Net loss:(5,882)(4,006)
Other undisclosed net income attributable to parent2,521 
Net loss attributable to parent:(3,362)(4,006)
Preferred stock dividends and other adjustments(2,193) 
Net loss available to common stockholders, diluted:(5,554)(4,006)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(5,882)(4,006)
Comprehensive loss, net of tax, attributable to parent:(5,882)(4,006)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: